Effects of Oral Liposomal Glutathione in Altering the Immune Responses Against Mycobacterium tuberculosis and the Mycobacterium bovis BCG Strain in Individuals With Type 2 Diabetes

The World Health Organization (WHO) has identified type 2 diabetes (T2DM) as a neglected, important, and re-emerging risk factor for tuberculosis (TB), especially in low and middle-income countries where TB is endemic. In this clinical trial study, oral liposomal glutathione supplementation (L-GSH)...

Descripción completa

Detalles Bibliográficos
Autores principales: To, Kimberly, Cao, Ruoqiong, Yegiazaryan, Aram, Owens, James, Nguyen, Timothy, Sasaninia, Kayvan, Vaughn, Charles, Singh, Mohkam, Truong, Edward, Medina, Albert, Avitia, Edith, Villegas, Jose, Pham, Christal, Sathananthan, Airani, Venketaraman, Vishwanath
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cellular and Infection Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211104/
https://www.ncbi.nlm.nih.gov/pubmed/34150674
http://dx.doi.org/10.3389/fcimb.2021.657775

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211104/
https://www.ncbi.nlm.nih.gov/pubmed/34150674
http://dx.doi.org/10.3389/fcimb.2021.657775

Ejemplares similares